ANIFROLUMAB-FNIA

ANIFROLUMAB-FNIA was reported 1921 times

ANIFROLUMAB-FNIA is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 INFUSION SITE JOINT PAIN 1 0.2500
1 NEUROENDOCRINE CARCINOMA OF THE OESOPHAGUS 1 0.2500
2 HERPES SIMPLEX VIRUS URETHRITIS 1 0.2500
3 KIDNEY HYPERMOBILITY 1 0.2000
4 LACRIMAL GLAND OPERATION 1 0.1429
5 IMMUNOMODULATORY THERAPY 1 0.1429
6 LUPUS MYOSITIS 1 0.1111
7 CORONAVIRUS TEST 1 0.1000
8 INSULIN THERAPY 1 0.0833
9 ABDOMINAL WALL PAIN 1 0.0588
10 INTESTINAL ANGINA 2 0.0476
11 COELIAC ARTERY OCCLUSION 2 0.0385
12 LISFRANC FRACTURE 1 0.0385
13 ENCHONDROMATOSIS 3 0.0349
14 FUNGAL MYOSITIS 1 0.0286
15 DISSEMINATED VARICELLA 1 0.0263
16 HERPES ZOSTER MENINGOMYELITIS 1 0.0233
17 MENINGITIS ENTEROVIRAL 2 0.0215
18 LUPUS NEPHRITIS 39 0.0208
19 DETACHMENT OF MACULAR RETINAL PIGMENT EPITHELIUM 1 0.0192
20 LUPUS VASCULITIS 2 0.0185
21 LUPUS PNEUMONITIS 2 0.0179
22 LUPUS ENTERITIS 1 0.0169
23 NEUROPSYCHIATRIC LUPUS 2 0.0165
24 DISSEMINATED HERPES SIMPLEX 1 0.0135
25 CENTRAL NERVOUS SYSTEM LUPUS 3 0.0135
26 MACULAR THICKENING 1 0.0119
27 OPHTHALMIC VASCULAR THROMBOSIS 1 0.0118
28 LYMPHOCYTE COUNT 1 0.0114
29 INFUSION SITE HYPOAESTHESIA 1 0.0105
30 INFUSION SITE PAPULE 1 0.0105
31 METAPNEUMOVIRUS PNEUMONIA 1 0.0104
32 GENITAL HERPES SIMPLEX 2 0.0094
33 CATHETER SITE SCAB 1 0.0093
34 CHOROID MELANOMA 1 0.0088
35 DOUBLE STRANDED DNA ANTIBODY 1 0.0088
36 EOSINOPHIL COUNT 1 0.0086
37 GENERAL PHYSICAL CONDITION 1 0.0085
38 HERPES SIMPLEX HEPATITIS 2 0.0083
39 MESENTERIC ARTERY STENOSIS 1 0.0082
40 GENITAL NEOPLASM MALIGNANT FEMALE 1 0.0081
41 BUTTERFLY RASH 8 0.0079
42 INFUSION 3 0.0073
43 CARDITIS 3 0.0072
44 MESENTERIC ARTERIAL OCCLUSION 1 0.0071
45 TEMPOROMANDIBULAR PAIN AND DYSFUNCTION SYNDROME 3 0.0070
46 NECROTISING SCLERITIS 1 0.0069
47 MENINGITIS STREPTOCOCCAL 1 0.0068
48 MENINGOENCEPHALITIS BACTERIAL 1 0.0068
49 MUCOSAL HYPERTROPHY 1 0.0068
50 CHRONIC CUTANEOUS LUPUS ERYTHEMATOSUS 3 0.0067
51 CARBOHYDRATE ANTIGEN 27.29 INCREASED 1 0.0067
52 MESANGIOPROLIFERATIVE GLOMERULONEPHRITIS 1 0.0065
53 MUCOCUTANEOUS DISORDER 1 0.0063
54 BREAST DISCOLOURATION 1 0.0063
55 BLOOD PRESSURE ORTHOSTATIC 1 0.0063
56 BONE FISTULA 1 0.0063
57 ANALGESIC THERAPY 2 0.0062
58 MENINGITIS HERPES 1 0.0061
59 CATHETER SITE IRRITATION 2 0.0060
60 CHONDRITIS 1 0.0057
61 MUSCLE HYPERTROPHY 2 0.0057
62 MOLLUSCUM CONTAGIOSUM 3 0.0056
63 DISSEMINATED VARICELLA ZOSTER VIRUS INFECTION 2 0.0055
64 HERPES ZOSTER MENINGITIS 1 0.0055
65 CARDIOLIPIN ANTIBODY POSITIVE 1 0.0055
66 SEROSITIS 3 0.0054
67 ACANTHOSIS NIGRICANS 1 0.0054
68 HYPOCOAGULABLE STATE 5 0.0051
69 HERPES SIMPLEX TEST POSITIVE 1 0.0050
70 NASAL HERPES 1 0.0049
71 ABNORMAL CLOTTING FACTOR 1 0.0049
72 SYSTEMIC LUPUS ERYTHEMATOSUS 168 0.0047
73 FEMALE REPRODUCTIVE TRACT DISORDER 1 0.0046
74 NODULAR RASH 1 0.0045
75 INFUSION SITE URTICARIA 3 0.0045
76 ALDOLASE INCREASED 1 0.0044
77 INFECTIVE TENOSYNOVITIS 1 0.0040
78 HERPES ZOSTER OTICUS 2 0.0039
79 SYSTEMIC LUPUS ERYTHEMATOSUS RASH 3 0.0038
80 KETONURIA 3 0.0037
81 BINOCULAR EYE MOVEMENT DISORDER 1 0.0035
82 ANTIPHOSPHOLIPID ANTIBODIES POSITIVE 2 0.0034
83 ERYTHEMA ANNULARE 1 0.0034
84 CREATININE URINE INCREASED 1 0.0033
85 ENTEROCOLITIS VIRAL 1 0.0033
86 NASAL ULCER 5 0.0031
87 NASAL CRUSTING 2 0.0031
88 CELLULITE 1 0.0031
89 DOUBLE STRANDED DNA ANTIBODY POSITIVE 1 0.0031
90 DIFFUSE LARGE B-CELL LYMPHOMA STAGE IV 1 0.0030
91 MASS EXCISION 1 0.0029
92 ENTERITIS INFECTIOUS 5 0.0029
93 CUTANEOUS SYMPTOM 2 0.0029
94 HUMAN HERPESVIRUS 6 INFECTION REACTIVATION 1 0.0028
95 GASTROINTESTINAL MICROORGANISM OVERGROWTH 1 0.0028
96 INFUSION SITE INFLAMMATION 2 0.0028
97 CYTOMEGALOVIRUS HEPATITIS 1 0.0028
98 NONINFECTIVE ENCEPHALITIS 2 0.0028
99 HERPES ZOSTER MENINGOENCEPHALITIS 1 0.0028
100 SYSTEMIC SCLERODERMA 2 0.0027
101 MENINGITIS PNEUMOCOCCAL 1 0.0027
102 CYTOMEGALOVIRUS OESOPHAGITIS 1 0.0027
103 NEPHRITIS 9 0.0027
104 HERPES SIMPLEX REACTIVATION 1 0.0026
105 PRODUCT INEFFECTIVE 2 0.0025
106 INCISION SITE IMPAIRED HEALING 1 0.0025
107 MIXED CONNECTIVE TISSUE DISEASE 1 0.0024
108 HEPATITIS A 2 0.0024
109 GASTROINTESTINAL HYPERMOTILITY 1 0.0023
110 BLADDER HYPERTROPHY 1 0.0023
111 MENINGOENCEPHALITIS HERPETIC 1 0.0022
112 INFUSION SITE PRURITUS 7 0.0022
113 MUSCLE SWELLING 2 0.0022
114 MONONEUROPATHY MULTIPLEX 1 0.0022
115 PERICARDITIS 36 0.0021
116 CONNECTIVE TISSUE DISORDER 3 0.0021
117 HEPATIC HAEMATOMA 1 0.0021
118 CUTANEOUS LUPUS ERYTHEMATOSUS 4 0.0021
119 IMMUNODEFICIENCY COMMON VARIABLE 1 0.0020
120 INSURANCE ISSUE 31 0.0020
121 ENCEPHALITIS HERPES 1 0.0020
122 PLEURISY 12 0.0020
123 CAPILLARY FRAGILITY 1 0.0020
124 MENINGITIS LISTERIA 1 0.0020
125 HERPES VIRUS INFECTION 11 0.0019
126 PALMOPLANTAR PUSTULOSIS 1 0.0019
127 PNEUMONIA LEGIONELLA 3 0.0019
128 CORNEAL EROSION 1 0.0019
129 HYPERTROPHY 1 0.0018
130 BLOOD MAGNESIUM ABNORMAL 1 0.0018
131 PAPILLOEDEMA 8 0.0018
132 OCCIPITAL NEURALGIA 1 0.0018
133 LEGIONELLA INFECTION 1 0.0017
134 ENANTHEMA 1 0.0017
135 OPHTHALMIC HERPES SIMPLEX 1 0.0017
136 CELLULITIS ORBITAL 1 0.0017
137 STREPTOCOCCAL SEPSIS 2 0.0017
138 HYPERTENSIVE ENCEPHALOPATHY 1 0.0017
139 MENINGOMYELOCELE 1 0.0017
140 HYPERGAMMAGLOBULINAEMIA BENIGN MONOCLONAL 1 0.0016
141 HELLP SYNDROME 1 0.0016
142 ALLERGY TO CHEMICALS 2 0.0016
143 MONOCLONAL GAMMOPATHY 1 0.0016
144 HEPATITIS B REACTIVATION 5 0.0016
145 CHORIORETINITIS 1 0.0016
146 HERPES OPHTHALMIC 2 0.0015
147 GINGIVAL DISCOMFORT 1 0.0015
148 ILEAL PERFORATION 1 0.0015
149 NEUROMYELITIS OPTICA SPECTRUM DISORDER 2 0.0015
150 AORTITIS 1 0.0015
151 HYPERPARATHYROIDISM 3 0.0015
152 LIVEDO RETICULARIS 3 0.0014
153 H1N1 INFLUENZA 2 0.0014
154 MYELITIS TRANSVERSE 2 0.0014
155 CRYOGLOBULINAEMIA 1 0.0014
156 POST HERPETIC NEURALGIA 2 0.0014
157 DENTAL RESTORATION FAILURE 1 0.0014
158 EXPOSURE TO COMMUNICABLE DISEASE 1 0.0013
159 PROTEINURIA 25 0.0013
160 CREATINE KINASE INCREASED 1 0.0013
161 MYASTHENIC SYNDROME 1 0.0013
162 BLISTER INFECTED 1 0.0013
163 SCLERITIS 2 0.0012
164 ANTIPHOSPHOLIPID SYNDROME 2 0.0012
165 EXCESSIVE GRANULATION TISSUE 1 0.0012
166 FEAR OF FALLING 1 0.0012
167 CIRCADIAN RHYTHM SLEEP DISORDER 1 0.0012
168 HERPES ZOSTER 69 0.0012
169 MYCOTIC ALLERGY 1 0.0012
170 ALLERGIC SINUSITIS 1 0.0012
171 GENITAL BURNING SENSATION 1 0.0012
172 ENDOCRINE OPHTHALMOPATHY 1 0.0012
173 SKIN HYPOPIGMENTATION 2 0.0011
174 ANOGENITAL WARTS 1 0.0011
175 CATHETER MANAGEMENT 1 0.0011
176 BLOOD MAGNESIUM INCREASED 1 0.0011
177 OROPHARYNGEAL CANDIDIASIS 1 0.0011
178 CUTANEOUS VASCULITIS 4 0.0011
179 HERPES SIMPLEX 7 0.0011
180 CATHETER SITE SWELLING 1 0.0011
181 OVARIAN DISORDER 1 0.0011
182 ELECTROCARDIOGRAM CHANGE 1 0.0011
183 DUST ALLERGY 1 0.0010
184 JOINT NOISE 2 0.0010
185 LARGE INTESTINAL STENOSIS 2 0.0010
186 IMMUNE-MEDIATED DERMATITIS 1 0.0010
187 DRUG EXPOSURE BEFORE PREGNANCY 1 0.0010
188 BENIGN BREAST NEOPLASM 1 0.0010
189 CONJUNCTIVAL OEDEMA 1 0.0010
190 BONE MARROW OEDEMA 1 0.0010
191 HYPOSPADIAS 2 0.0010
192 CATHETER SITE ERYTHEMA 2 0.0009
193 ORCHITIS 1 0.0009
194 AMAUROSIS FUGAX 1 0.0009
195 INFECTION SUSCEPTIBILITY INCREASED 2 0.0009
196 INFUSION SITE HAEMORRHAGE 3 0.0009
197 NAIL GROWTH ABNORMAL 1 0.0009
198 BACTERIAL TEST POSITIVE 2 0.0009
199 BRAIN FOG 14 0.0009
200 GLOMERULONEPHRITIS RAPIDLY PROGRESSIVE 1 0.0009
201 CATHETER SITE DISCHARGE 1 0.0009
202 PERIARTHRITIS 2 0.0009
203 CHEMICAL BURN 1 0.0009
204 VASCULITIS 10 0.0009
205 MAGNETIC RESONANCE IMAGING ABNORMAL 1 0.0008
206 VARICELLA 2 0.0008
207 ESCHERICHIA TEST POSITIVE 1 0.0008
208 SCLERODERMA 3 0.0008
209 JOINT WARMTH 1 0.0008
210 AUTOIMMUNE THYROIDITIS 3 0.0008
211 OSTEITIS 2 0.0008
212 GLUCOSE URINE PRESENT 1 0.0008
213 ENDOCRINE DISORDER 1 0.0008
214 CATHETER SITE PAIN 2 0.0008
215 APPLICATION SITE PARAESTHESIA 1 0.0008
216 MULTIPLE ALLERGIES 6 0.0008
217 POLYARTHRITIS 4 0.0008
218 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 2 0.0008
219 INFUSION SITE RASH 1 0.0007
220 CHRONIC FATIGUE SYNDROME 1 0.0007
221 GLOMERULAR FILTRATION RATE ABNORMAL 1 0.0007
222 NEUROLOGICAL SYMPTOM 4 0.0007
223 INJECTION SITE HYPOAESTHESIA 1 0.0007
224 INFUSION SITE PAIN 9 0.0007
225 NAIL INFECTION 1 0.0007
226 NOROVIRUS INFECTION 1 0.0007
227 ENTEROCOLITIS 4 0.0007
228 NONINFECTIVE GINGIVITIS 1 0.0007
229 IMPETIGO 1 0.0007
230 SYMPTOM RECURRENCE 4 0.0007
231 MENTAL FATIGUE 1 0.0007
232 LUNG ADENOCARCINOMA 2 0.0007
233 VASCULAR DEVICE INFECTION 3 0.0007
234 URINE ABNORMALITY 3 0.0007
235 AGE-RELATED MACULAR DEGENERATION 1 0.0007
236 THERAPEUTIC PRODUCT EFFECT DELAYED 3 0.0007
237 GENITAL HERPES 1 0.0007
238 DYSPAREUNIA 3 0.0007
239 OPHTHALMOPLEGIA 1 0.0006
240 LIMB DEFORMITY 1 0.0006
241 INCORRECT DOSE ADMINISTERED BY PRODUCT 1 0.0006
242 RASH VESICULAR 3 0.0006
243 ANTINUCLEAR ANTIBODY POSITIVE 2 0.0006
244 COSTOCHONDRITIS 1 0.0006
245 PHARYNGEAL SWELLING 6 0.0006
246 MYOCARDITIS 7 0.0006
247 METABOLIC SYNDROME 1 0.0006
248 IMMUNE SYSTEM DISORDER 8 0.0006
249 UPPER-AIRWAY COUGH SYNDROME 5 0.0006
250 PHOTOSENSITIVITY REACTION 10 0.0006
251 PROTEIN URINE PRESENT 3 0.0006
252 LINEAR IGA DISEASE 1 0.0006
253 MENINGITIS 4 0.0006
254 ENDOCARDITIS 3 0.0006
255 VARICOSE VEIN 3 0.0006
256 POLYMENORRHOEA 2 0.0006
257 KIDNEY FIBROSIS 1 0.0006
258 DRUG SCREEN NEGATIVE 1 0.0006
259 HISTOPLASMOSIS 1 0.0006
260 AORTIC VALVE STENOSIS 1 0.0006
261 PYODERMA GANGRENOSUM 2 0.0006
262 OPHTHALMIC HERPES ZOSTER 1 0.0006
263 DERMATITIS BULLOUS 4 0.0006
264 BLOOD HIV RNA INCREASED 1 0.0006
265 IMMUNE-MEDIATED LUNG DISEASE 1 0.0005
266 PARADOXICAL DRUG REACTION 2 0.0005
267 BODY TEMPERATURE ABNORMAL 1 0.0005
268 DRUG EFFECT LESS THAN EXPECTED 8 0.0005
269 HEART RATE ABNORMAL 3 0.0005
270 LYMPH NODE PAIN 1 0.0005
271 RESPIRATORY TRACT INFECTION 14 0.0005
272 THROAT CLEARING 2 0.0005
273 CYSTOID MACULAR OEDEMA 1 0.0005
274 INTERVERTEBRAL DISCITIS 1 0.0005
275 MYELOPATHY 1 0.0005
276 OSTEOPOROTIC FRACTURE 1 0.0005
277 OCULAR HYPERTENSION 1 0.0005
278 OESOPHAGEAL CANDIDIASIS 2 0.0005
279 HYPERPHAGIA 2 0.0005
280 MYASTHENIA GRAVIS 4 0.0005
281 VITAMIN B12 DEFICIENCY 2 0.0005
282 INTERNATIONAL NORMALISED RATIO DECREASED 2 0.0005
283 FOETAL GROWTH RESTRICTION 3 0.0005
284 DERMATITIS PSORIASIFORM 1 0.0005
285 INTERNATIONAL NORMALISED RATIO FLUCTUATION 1 0.0005
286 HYPERBILIRUBINAEMIA 5 0.0005
287 INFUSION SITE ERYTHEMA 4 0.0005
288 NEUROGENIC BLADDER 1 0.0005
289 OPTIC NEUROPATHY 1 0.0005
290 FOREIGN BODY SENSATION IN EYES 3 0.0005
291 HEPATIC CYTOLYSIS 6 0.0005
292 ANAEMIA MACROCYTIC 1 0.0005
293 INTERVERTEBRAL DISC DISORDER 2 0.0005
294 CD4 LYMPHOCYTES DECREASED 1 0.0005
295 EXOPHTHALMOS 1 0.0005
296 OESOPHAGITIS 5 0.0005
297 HENOCH-SCHONLEIN PURPURA 1 0.0005
298 DYSPHEMIA 2 0.0005
299 IMMUNOSUPPRESSION 4 0.0005
300 INFUSION RELATED REACTION 30 0.0005
301 FEAR OF DEATH 1 0.0004
302 IDIOPATHIC INTRACRANIAL HYPERTENSION 1 0.0004
303 COMPUTERISED TOMOGRAM ABNORMAL 1 0.0004
304 KOUNIS SYNDROME 1 0.0004
305 IMMUNE THROMBOCYTOPENIA 2 0.0004
306 ILLNESS 45 0.0004
307 DENGUE FEVER 1 0.0004
308 PNEUMONIA BACTERIAL 4 0.0004
309 CYTOMEGALOVIRUS COLITIS 1 0.0004
310 BLOOD PRESSURE DIASTOLIC INCREASED 2 0.0004
311 BREAKTHROUGH PAIN 1 0.0004
312 FLAT AFFECT 1 0.0004
313 PRODUCT DISTRIBUTION ISSUE 4 0.0004
314 RENAL FUNCTION TEST ABNORMAL 2 0.0004
315 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 1 0.0004
316 MENOPAUSAL SYMPTOMS 1 0.0004
317 DISCOURAGEMENT 1 0.0004
318 INGROWING NAIL 1 0.0004
319 CARDIAC TAMPONADE 2 0.0004
320 BRONCHOSPASM 6 0.0004
321 SUPRAVENTRICULAR TACHYCARDIA 4 0.0004
322 PARAESTHESIA ORAL 6 0.0004
323 PANIC REACTION 3 0.0004
324 LYMPHADENITIS 1 0.0004
325 AUTOIMMUNE DISORDER 4 0.0004
326 HORMONE LEVEL ABNORMAL 2 0.0004
327 INFLAMMATION 21 0.0004
328 DEVICE INFUSION ISSUE 1 0.0004
329 INFREQUENT BOWEL MOVEMENTS 1 0.0004
330 VEIN DISORDER 2 0.0004
331 ERYSIPELAS 2 0.0004
332 DERMATOMYOSITIS 1 0.0004
333 HAEMORRHAGE URINARY TRACT 1 0.0004
334 ANGLE CLOSURE GLAUCOMA 1 0.0004
335 ABDOMINAL INFECTION 1 0.0004
336 LACTOSE INTOLERANCE 1 0.0004
337 LIP SWELLING 13 0.0004
338 MENOPAUSE 1 0.0004
339 POOR VENOUS ACCESS 4 0.0004
340 NASAL DISORDER 1 0.0004
341 BLOOD POTASSIUM ABNORMAL 1 0.0004
342 COMPRESSION FRACTURE 2 0.0004
343 EAR CONGESTION 1 0.0004
344 INVASIVE DUCTAL BREAST CARCINOMA 1 0.0004
345 LIP BLISTER 1 0.0004
346 CHOKING SENSATION 2 0.0004
347 MENSTRUAL DISORDER 3 0.0004
348 ANAPHYLACTIC REACTION 20 0.0004
349 VIRAL INFECTION 12 0.0004
350 ORAL HERPES 7 0.0004
351 INTERMENSTRUAL BLEEDING 2 0.0004
352 ELECTRIC SHOCK SENSATION 1 0.0004
353 SKIN REACTION 5 0.0004
354 EYE INFECTION 4 0.0004
355 JOINT LOCK 1 0.0004
356 BLOOD PRESSURE ABNORMAL 7 0.0004
357 SKIN ATROPHY 2 0.0003
358 FIBULA FRACTURE 1 0.0003
359 MOUTH SWELLING 2 0.0003
360 UPPER RESPIRATORY TRACT INFECTION 16 0.0003
361 ABORTION 1 0.0003
362 LUMBAR SPINAL STENOSIS 1 0.0003
363 GRIP STRENGTH DECREASED 3 0.0003
364 HEPATITIS FULMINANT 1 0.0003
365 CREPITATIONS 1 0.0003
366 ATYPICAL PNEUMONIA 1 0.0003
367 CEREBROVASCULAR DISORDER 1 0.0003
368 HEPATITIS B 2 0.0003
369 CENTRAL VENOUS CATHETERISATION 1 0.0003
370 HIDRADENITIS 3 0.0003
371 DYSAESTHESIA 1 0.0003
372 INCREASED TENDENCY TO BRUISE 3 0.0003
373 NEPHROPATHY 3 0.0003
374 ELECTROENCEPHALOGRAM ABNORMAL 1 0.0003
375 LOOSE TOOTH 1 0.0003
376 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 2 0.0003
377 THERAPY CHANGE 3 0.0003
378 LISTLESS 1 0.0003
379 TOOTH INFECTION 4 0.0003
380 CORONAVIRUS INFECTION 2 0.0003
381 BRAIN INJURY 3 0.0003
382 PNEUMOCYSTIS JIROVECII PNEUMONIA 3 0.0003
383 POSTOPERATIVE WOUND INFECTION 2 0.0003
384 GENERAL PHYSICAL CONDITION ABNORMAL 2 0.0003
385 PRODUCT LABEL ISSUE 2 0.0003
386 ARTHRITIS 23 0.0003
387 AUTOIMMUNE HAEMOLYTIC ANAEMIA 1 0.0003
388 TEMPERATURE INTOLERANCE 3 0.0003
389 COVID-19 51 0.0003
390 DEPRESSION SUICIDAL 1 0.0003
391 MICTURITION DISORDER 1 0.0003
392 EAR PRURITUS 1 0.0003
393 BLINDNESS UNILATERAL 4 0.0003
394 CHEST DISCOMFORT 29 0.0003
395 LYMPHADENOPATHY 10 0.0003
396 DRUG ERUPTION 5 0.0003
397 MACULOPATHY 1 0.0003
398 THERMAL BURN 2 0.0003
399 BLOOD PHOSPHORUS DECREASED 1 0.0003
400 THERAPEUTIC RESPONSE SHORTENED 9 0.0003
401 BLINDNESS TRANSIENT 2 0.0003
402 RED BLOOD CELL SEDIMENTATION RATE INCREASED 3 0.0003
403 HYPERACUSIS 1 0.0003
404 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 2 0.0003
405 PEMPHIGOID 2 0.0003
406 CATHETER SITE INFECTION 1 0.0003
407 AORTIC ANEURYSM 2 0.0003
408 ARTHRALGIA 109 0.0003
409 COMMUNICATION DISORDER 1 0.0003
410 TINNITUS 12 0.0003
411 OESOPHAGEAL DISORDER 1 0.0003
412 LYMPHOMA 4 0.0003
413 THROAT TIGHTNESS 7 0.0003
414 EPIGASTRIC DISCOMFORT 1 0.0003
415 GASTROINTESTINAL INFLAMMATION 2 0.0003
416 KIDNEY INFECTION 5 0.0003
417 COVID-19 PNEUMONIA 3 0.0003
418 ULCER 4 0.0003
419 GINGIVAL PAIN 2 0.0003
420 ATRIAL FLUTTER 2 0.0003
421 ARTERIOSPASM CORONARY 1 0.0002
422 MUSCLE HAEMORRHAGE 1 0.0002
423 CYSTITIS HAEMORRHAGIC 1 0.0002
424 FRUSTRATION TOLERANCE DECREASED 2 0.0002
425 EXTRAVASATION 1 0.0002
426 ESCHERICHIA INFECTION 2 0.0002
427 HAIR DISORDER 2 0.0002
428 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 2 0.0002
429 GENERALISED OEDEMA 3 0.0002
430 PHARYNGITIS 3 0.0002
431 COAGULOPATHY 4 0.0002
432 ONYCHOMADESIS 1 0.0002
433 ATTENTION DEFICIT HYPERACTIVITY DISORDER 1 0.0002
434 SENSATION OF FOREIGN BODY 2 0.0002
435 LABORATORY TEST ABNORMAL 7 0.0002
436 HYPERPYREXIA 1 0.0002
437 LIP OEDEMA 1 0.0002
438 RENAL DISORDER 11 0.0002
439 SWELLING 22 0.0002
440 INCORRECT DRUG ADMINISTRATION RATE 1 0.0002
441 ABNORMAL SENSATION IN EYE 1 0.0002
442 METASTATIC NEOPLASM 1 0.0002
443 MONOPLEGIA 1 0.0002
444 GROIN PAIN 2 0.0002
445 ABDOMINAL ABSCESS 1 0.0002
446 SWOLLEN TONGUE 7 0.0002
447 ILEUS PARALYTIC 1 0.0002
448 JOINT SWELLING 27 0.0002
449 MYOSITIS 2 0.0002
450 MENINGITIS ASEPTIC 1 0.0002
451 SYNOVITIS 4 0.0002
452 UVEITIS 3 0.0002
453 OPTIC NEURITIS 2 0.0002
454 HAEMOGLOBIN INCREASED 1 0.0002
455 EXOSTOSIS 2 0.0002
456 DISEASE COMPLICATION 1 0.0002
457 PERICARDIAL EFFUSION 5 0.0002
458 OROPHARYNGEAL PAIN 20 0.0002
459 INTERCEPTED MEDICATION ERROR 1 0.0002
460 SWELLING FACE 14 0.0002
461 URTICARIA 36 0.0002
462 SINUSITIS 22 0.0002
463 FLANK PAIN 2 0.0002
464 ARTERIOSCLEROSIS 2 0.0002
465 LYMPHOPENIA 3 0.0002
466 PRODUCT DOSE OMISSION ISSUE 62 0.0002
467 SKIN DISORDER 7 0.0002
468 MIGRAINE 20 0.0002
469 HUMERUS FRACTURE 1 0.0002
470 ENTEROCOCCAL INFECTION 1 0.0002
471 COMPLICATION ASSOCIATED WITH DEVICE 3 0.0002
472 NEURALGIA 5 0.0002
473 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 37 0.0002
474 DECREASED IMMUNE RESPONSIVENESS 2 0.0002
475 BRONCHITIS 15 0.0002
476 FOOT OPERATION 1 0.0002
477 INFLAMMATORY MARKER INCREASED 1 0.0002
478 BLADDER DISORDER 2 0.0002
479 IMMUNODEFICIENCY 3 0.0002
480 THROAT IRRITATION 9 0.0002
481 OVARIAN CYST 2 0.0002
482 CHEST PAIN 37 0.0002
483 KLEBSIELLA INFECTION 1 0.0002
484 FEEDING DISORDER 4 0.0002
485 TASTE DISORDER 4 0.0002
486 DYSLIPIDAEMIA 1 0.0002
487 BLISTER 11 0.0002
488 MYALGIA 33 0.0002
489 CONDITION AGGRAVATED 59 0.0002
490 ANAPHYLACTIC SHOCK 5 0.0002
491 C-REACTIVE PROTEIN INCREASED 7 0.0002
492 THERAPY PARTIAL RESPONDER 3 0.0002
493 FEELING ABNORMAL 46 0.0002
494 JOINT STIFFNESS 5 0.0002
495 PRODUCT USE COMPLAINT 3 0.0002
496 MOUTH ULCERATION 4 0.0002
497 FATIGUE 147 0.0002
498 EYE SWELLING 7 0.0002
499 ABSCESS 3 0.0002
500 RETCHING 4 0.0002
501 INFECTION 27 0.0002
502 INJECTION SITE DISCHARGE 1 0.0002
503 DECREASED ACTIVITY 2 0.0002
504 CHEILITIS 1 0.0002
505 DEAFNESS UNILATERAL 1 0.0002
506 CYTOMEGALOVIRUS INFECTION 3 0.0002
507 LEUKOPENIA 9 0.0002
508 RASH 78 0.0002
509 SNEEZING 4 0.0002
510 SKIN INFECTION 2 0.0002
511 MULTIPLE USE OF SINGLE-USE PRODUCT 1 0.0002
512 MUSCULOSKELETAL DISCOMFORT 3 0.0002
513 PARANOIA 3 0.0002
514 RASH MACULAR 6 0.0002
515 BURNING SENSATION 12 0.0002
516 BONE PAIN 10 0.0002
517 DECREASED INTEREST 1 0.0002
518 ENERGY INCREASED 1 0.0002
519 PSYCHOTIC DISORDER 5 0.0002
520 POLLAKIURIA 7 0.0002
521 MACULAR DEGENERATION 2 0.0002
522 HYPERSENSITIVITY 31 0.0002
523 THYROID CANCER 2 0.0002
524 TOOTHACHE 3 0.0002
525 OSTEOMYELITIS 3 0.0002
526 LOCALISED INFECTION 4 0.0002
527 ADRENAL INSUFFICIENCY 2 0.0002
528 NOCTURIA 2 0.0002
529 FIBROMYALGIA 4 0.0002
530 DYSURIA 6 0.0002
531 ALOPECIA 32 0.0002
532 CONCOMITANT DISEASE AGGRAVATED 1 0.0002
533 ILEUS 2 0.0002
534 EXPOSURE DURING PREGNANCY 10 0.0002
535 INFUSION SITE EXTRAVASATION 1 0.0002
536 NERVOUS SYSTEM DISORDER 5 0.0002
537 EPSTEIN-BARR VIRUS INFECTION 1 0.0002
538 INFUSION SITE SWELLING 1 0.0002
539 FOOT FRACTURE 3 0.0002
540 FLUSHING 16 0.0002
541 FLUID RETENTION 8 0.0002
542 INTRAOCULAR PRESSURE INCREASED 2 0.0002
543 HEADACHE 98 0.0002
544 LOWER LIMB FRACTURE 3 0.0002
545 C-REACTIVE PROTEIN ABNORMAL 1 0.0002
546 EAR PAIN 3 0.0002
547 NEPHROLITHIASIS 7 0.0002
548 ORAL CANDIDIASIS 2 0.0002
549 SINUS DISORDER 3 0.0002
550 ARTERIOSCLEROSIS CORONARY ARTERY 1 0.0002
551 BLOOD PRESSURE DECREASED 10 0.0002
552 GAIT INABILITY 5 0.0001
553 MALIGNANT MELANOMA 2 0.0001
554 JOINT RANGE OF MOTION DECREASED 2 0.0001
555 BREAST MASS 1 0.0001
556 BODY TEMPERATURE INCREASED 3 0.0001
557 URINARY TRACT INFECTION 25 0.0001
558 GINGIVAL BLEEDING 2 0.0001
559 HAEMATURIA 5 0.0001
560 NEPHROTIC SYNDROME 1 0.0001
561 PERIPHERAL COLDNESS 2 0.0001
562 ENCEPHALITIS 1 0.0001
563 PYREXIA 50 0.0001
564 HYPERTRANSAMINASAEMIA 1 0.0001
565 INFLUENZA 16 0.0001
566 APHONIA 2 0.0001
567 EXTRASYSTOLES 1 0.0001
568 APPLICATION SITE REACTION 1 0.0001
569 SEASONAL ALLERGY 2 0.0001
570 INTENTIONAL DOSE OMISSION 4 0.0001
571 PARALYSIS 2 0.0001
572 PULMONARY ARTERIAL HYPERTENSION 2 0.0001
573 HYPOKINESIA 2 0.0001
574 PRODUCT PRESCRIBING ISSUE 3 0.0001
575 INTERVERTEBRAL DISC PROTRUSION 3 0.0001
576 MAJOR DEPRESSION 1 0.0001
577 ORAL DISORDER 1 0.0001
578 NASAL CONGESTION 8 0.0001
579 CARDIOMYOPATHY 2 0.0001
580 ARTHROPOD BITE 1 0.0001
581 TOOTH DISORDER 3 0.0001
582 FEELING DRUNK 1 0.0001
583 PULMONARY MASS 2 0.0001
584 RASH PAPULAR 3 0.0001
585 HYPOAESTHESIA 20 0.0001
586 GENERAL SYMPTOM 1 0.0001
587 PRURITUS 51 0.0001
588 INTERCEPTED PRODUCT ADMINISTRATION ERROR 1 0.0001
589 THYROID DISORDER 2 0.0001
590 HAEMOLYSIS 1 0.0001
591 ANKLE FRACTURE 2 0.0001
592 TENDONITIS 2 0.0001
593 OEDEMA 7 0.0001
594 PAIN 79 0.0001
595 COUGH 36 0.0001
596 AFFECTIVE DISORDER 1 0.0001
597 PNEUMOTHORAX 2 0.0001
598 CYSTITIS 4 0.0001
599 MUSCULOSKELETAL STIFFNESS 11 0.0001
600 BLOOD PRESSURE FLUCTUATION 3 0.0001
601 BLOOD DISORDER 1 0.0001
602 ABORTION SPONTANEOUS 5 0.0001
603 BLOOD PRESSURE INCREASED 19 0.0001
604 NIGHT SWEATS 4 0.0001
605 MUSCLE TIGHTNESS 2 0.0001
606 ABNORMAL FAECES 1 0.0001
607 INFLUENZA LIKE ILLNESS 10 0.0001
608 HEART RATE INCREASED 12 0.0001
609 FUNGAL INFECTION 4 0.0001
610 SCAR 2 0.0001
611 SEPSIS 13 0.0001
612 ANURIA 1 0.0001
613 MYOPATHY 1 0.0001
614 STOMATITIS 7 0.0001
615 VERTIGO 7 0.0001
616 LUNG INFILTRATION 1 0.0001
617 HEAD DISCOMFORT 2 0.0001
618 EAR INFECTION 3 0.0001
619 SEIZURE 13 0.0001
620 FACIAL PAIN 1 0.0001
621 HAEMOLYTIC ANAEMIA 1 0.0001
622 GASTROINTESTINAL INFECTION 1 0.0001
623 PNEUMONIA 36 0.0001
624 NAUSEA 88 0.0001
625 LOSS OF LIBIDO 1 0.0001
626 HEAVY MENSTRUAL BLEEDING 1 0.0001
627 PALPITATIONS 13 0.0001
628 GASTROENTERITIS VIRAL 2 0.0001
629 OROPHARYNGEAL DISCOMFORT 1 0.0001
630 LUPUS-LIKE SYNDROME 1 0.0001
631 PNEUMONITIS 3 0.0001
632 CRYING 4 0.0001
633 BONE DISORDER 2 0.0001
634 SKIN LESION 3 0.0001
635 BRAIN NEOPLASM 1 0.0001
636 SKIN DISCOLOURATION 5 0.0001
637 BLOOD THYROID STIMULATING HORMONE INCREASED 1 0.0001
638 OVARIAN CANCER 1 0.0001
639 NERVE COMPRESSION 1 0.0001
640 PARAESTHESIA 17 0.0001
641 BREAST CANCER STAGE I 1 0.0001
642 HEPATIC STEATOSIS 2 0.0001
643 THROMBOCYTOPENIA 12 0.0001
644 BREAST CANCER 10 0.0001
645 BACTERIAL INFECTION 2 0.0001
646 HEPATIC FUNCTION ABNORMAL 4 0.0001
647 HEPATIC ENCEPHALOPATHY 1 0.0001
648 RENAL IMPAIRMENT 9 0.0001
649 APPENDICITIS 1 0.0001
650 OXYGEN SATURATION DECREASED 6 0.0001
651 OEDEMA PERIPHERAL 13 0.0001
652 ASTHENIA 40 0.0001
653 ABORTION INDUCED 1 0.0001
654 DYSPNOEA EXERTIONAL 4 0.0001
655 PAIN IN JAW 3 0.0001
656 COLITIS 4 0.0001
657 ABDOMINAL DISTENSION 11 0.0001
658 BLOOD URINE PRESENT 2 0.0001
659 LETHARGY 6 0.0001
660 PULMONARY FIBROSIS 2 0.0001
661 DIZZINESS 52 0.0001
662 HYPERCHOLESTEROLAEMIA 1 0.0001
663 ATELECTASIS 1 0.0001
664 ERUCTATION 2 0.0001
665 NASOPHARYNGITIS 19 0.0001
666 WEIGHT INCREASED 23 0.0001
667 ASCITES 3 0.0001
668 ACUTE MYOCARDIAL INFARCTION 3 0.0001
669 TACHYCARDIA 9 0.0001
670 URINARY INCONTINENCE 3 0.0001
671 DISORIENTATION 4 0.0001
672 INABILITY TO AFFORD MEDICATION 1 0.0001
673 DRY EYE 5 0.0001
674 VOMITING 47 0.0001
675 CONFUSIONAL STATE 16 0.0001
676 PLEURAL EFFUSION 6 0.0001
677 PAIN IN EXTREMITY 29 0.0001
678 EYELID PTOSIS 1 0.0001
679 DRY THROAT 1 0.0001
680 MOTOR DYSFUNCTION 1 0.0001
681 FEELING HOT 6 0.0001
682 NEUTROPHIL COUNT INCREASED 1 0.0001
683 EAR DISCOMFORT 1 0.0001
684 THERAPY CESSATION 5 0.0001
685 PERIPHERAL SWELLING 15 0.0001
686 OSTEOPOROSIS 4 0.0001
687 DYSPNOEA 55 0.0001
688 DYSPHAGIA 9 0.0001
689 INCONTINENCE 1 0.0001
690 DEPRESSED MOOD 5 0.0001
691 JOINT INJURY 2 0.0001
692 IRRITABLE BOWEL SYNDROME 2 0.0001
693 LIVER FUNCTION TEST INCREASED 2 0.0001
694 RHINORRHOEA 6 0.0001
695 BIPOLAR DISORDER 1 0.0001
696 PRODUCT DISPENSING ERROR 2 0.0001
697 IMPAIRED HEALING 3 0.0001
698 BLOOD GLUCOSE FLUCTUATION 1 0.0001
699 FOOT DEFORMITY 1 0.0001
700 LIVER DISORDER 4 0.0001
701 RASH MACULO-PAPULAR 2 0.0001
702 OBSTRUCTIVE AIRWAYS DISORDER 1 0.0001
703 HYPERTENSIVE CRISIS 1 0.0001
704 PULMONARY OEDEMA 4 0.0001
705 ORAL PAIN 2 0.0001
706 GASTROINTESTINAL DISORDER 8 0.0001
707 TRANSIENT ISCHAEMIC ATTACK 3 0.0001
708 ANGER 3 0.0001
709 ASTHMA 10 0.0001
710 PRODUCT AVAILABILITY ISSUE 2 0.0001
711 DERMATITIS CONTACT 1 0.0001
712 MICTURITION URGENCY 1 0.0001
713 CHOLECYSTECTOMY 1 0.0001
714 MEMORY IMPAIRMENT 12 0.0001
715 SHOCK 2 0.0001
716 GASTRIC HAEMORRHAGE 1 0.0001
717 DRY MOUTH 7 0.0001
718 ELECTROLYTE IMBALANCE 1 0.0001
719 EYELID OEDEMA 1 0.0001
720 HYPOXIA 3 0.0001
721 PLATELET COUNT DECREASED 9 0.0001
722 MALAISE 37 0.0001
723 BLOOD IRON DECREASED 1 0.0001
724 BACTERAEMIA 1 0.0001
725 NEUROPATHY PERIPHERAL 8 0.0001
726 DISEASE RECURRENCE 4 0.0001
727 PRODUCTIVE COUGH 4 0.0001
728 ACCIDENT 1 0.0001
729 ABDOMINAL DISCOMFORT 14 0.0001
730 DRUG INTOLERANCE 8 0.0001
731 BURSITIS 1 0.0001
732 WEIGHT DECREASED 23 0.0001
733 PRESYNCOPE 2 0.0001
734 DISCOMFORT 5 0.0001
735 CYTOPENIA 1 0.0001
736 LUNG DISORDER 4 0.0001
737 GLOMERULAR FILTRATION RATE DECREASED 1 0.0001
738 HYPERCALCAEMIA 1 0.0001
739 VISUAL IMPAIRMENT 10 0.0001
740 CYST 1 0.0001
741 HAIR COLOUR CHANGES 1 0.0001
742 HYPERTENSION 17 0.0001
743 INJECTION SITE DISCOLOURATION 1 0.0001
744 SYNCOPE 8 0.0001
745 CELLULITIS 4 0.0001
746 MUSCLE ATROPHY 1 0.0001
747 HYPOPHAGIA 2 0.0001
748 ERECTILE DYSFUNCTION 2 0.0001
749 METASTASES TO CENTRAL NERVOUS SYSTEM 1 0.0001
750 HAEMATOMA 2 0.0001
751 AMNESIA 5 0.0001
752 CHILLS 9 0.0001
753 CEREBROVASCULAR ACCIDENT 13 0.0001
754 NODULE 1 0.0001
755 DEAFNESS 2 0.0001
756 HAND DEFORMITY 1 0.0001
757 GASTRITIS 2 0.0001
758 DYSMENORRHOEA 1 0.0001
759 HAIR TEXTURE ABNORMAL 1 0.0001
760 DYSKINESIA 3 0.0001
761 RASH PRURITIC 4 0.0001
762 BLINDNESS 3 0.0001
763 NEUTROPENIA 10 0.0001
764 MOOD ALTERED 2 0.0001
765 ACUTE HEPATIC FAILURE 1 0.0001
766 BACK PAIN 17 0.0001
767 DEVICE DELIVERY SYSTEM ISSUE 2 0.0001
768 LUNG NEOPLASM MALIGNANT 3 0.0001
769 ERYTHEMA 15 0.0001
770 CONTUSION 7 0.0001
771 RESPIRATORY DISTRESS 2 0.0001
772 ABNORMAL DREAMS 2 0.0001
773 ORAL DISCOMFORT 1 0.0001
774 FEELING COLD 2 0.0001
775 HUNGER 1 0.0001
776 DEMENTIA 2 0.0001
777 WOUND 2 0.0001
778 BLOOD TEST ABNORMAL 1 0.0001
779 DISSEMINATED INTRAVASCULAR COAGULATION 1 0.0001
780 OSTEOARTHRITIS 3 0.0001
781 MULTIPLE ORGAN DYSFUNCTION SYNDROME 2 0.0001
782 RHEUMATOID ARTHRITIS 8 0.0001
783 MUSCULAR WEAKNESS 8 0.0001
784 HYPERSOMNIA 2 0.0001
785 CARDIOGENIC SHOCK 1 0.0001
786 MOBILITY DECREASED 5 0.0001
787 BLOOD CREATINE PHOSPHOKINASE INCREASED 2 0.0001
788 APATHY 1 0.0001
789 GASTROENTERITIS 1 0.0001
790 DYSSTASIA 2 0.0001
791 DYSPHONIA 4 0.0001
792 GAIT DISTURBANCE 13 0.0001
793 THERAPEUTIC RESPONSE UNEXPECTED 3 0.0001
794 BONE LOSS 1 0.0001
795 BLOOD POTASSIUM DECREASED 2 0.0001
796 HYPOAESTHESIA ORAL 1 0.0001
797 THERAPEUTIC RESPONSE DECREASED 4 0.0001
798 OSTEOPENIA 1 0.0001
799 DEVICE FAILURE 1 0.0001
800 HIP ARTHROPLASTY 1 0.0001
801 HYPOKALAEMIA 3 0.0001
802 DEVICE RELATED INFECTION 1 0.0001
803 EMOTIONAL DISORDER 2 0.0001
804 LIMB DISCOMFORT 2 0.0001
805 MUSCULOSKELETAL CHEST PAIN 1 0.0001
806 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 3 0.0001
807 INSOMNIA 17 0.0001
808 OCULAR HYPERAEMIA 3 0.0001
809 HEAD INJURY 2 0.0001
810 ABDOMINAL PAIN UPPER 13 0.0001
811 RASH ERYTHEMATOUS 3 0.0001
812 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 3 0.0001
813 CARDIAC FAILURE 5 0.0001
814 EYE DISORDER 2 0.0001
815 GENERALISED TONIC-CLONIC SEIZURE 1 0.0001
816 ABDOMINAL PAIN 14 0.0001
817 NEOPLASM MALIGNANT 4 0.0001
818 ANXIETY 17 0.0001
819 INJECTION SITE PRURITUS 4 0.0001
820 SOMNOLENCE 12 0.0001
821 FACE OEDEMA 1 0.0001
822 CANDIDA INFECTION 1 0.0001
823 HEMIPARESIS 1 0.0001
824 DIARRHOEA 38 0.0001
825 DEVICE DEFECTIVE 1 0.0001
826 EOSINOPHILIA 1 0.0001
827 AMENORRHOEA 1 0.0001
828 PANCREATITIS 3 0.0001
829 SLEEP DISORDER 4 0.0001
830 LYMPHOCYTE COUNT DECREASED 1 0.0001
831 DIABETES MELLITUS INADEQUATE CONTROL 1 0.0001
832 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 4 0.0001
833 THERAPY INTERRUPTED 4 0.0001
834 SKIN BURNING SENSATION 4 0.0001
835 GOUT 1 0.0001
836 NO ADVERSE EVENT 10 0.0001
837 PANIC ATTACK 2 0.0001
838 HYPOTENSION 11 0.0001
839 SUICIDAL IDEATION 5 0.0001
840 MUSCLE SPASMS 10 0.0001
841 BLOOD GLUCOSE ABNORMAL 1 0.0001
842 ARTHROPATHY 3 0.0001
843 CONJUNCTIVITIS 1 0.0001
844 AGRANULOCYTOSIS 1 0.0001
845 PANCYTOPENIA 3 0.0001
846 NECK PAIN 3 0.0001
847 MIDDLE INSOMNIA 1 0.0001
848 CARDIAC DISORDER 5 0.0001
849 HYPONATRAEMIA 3 0.0001
850 HOT FLUSH 4 0.0001
851 INTESTINAL OBSTRUCTION 2 0.0001
852 FLATULENCE 3 0.0001
853 DEPRESSION 12 0.0001
854 GASTRIC ULCER 1 0.0001
855 MUSCULOSKELETAL DISORDER 1 0.0001
856 FEELING JITTERY 1 0.0001
857 INCREASED APPETITE 1 0.0001
858 EYE IRRITATION 3 0.0001
859 ACUTE RESPIRATORY FAILURE 1 0.0001
860 GLAUCOMA 1 0.0001
861 GENERAL PHYSICAL HEALTH DETERIORATION 6 0.0001
862 OFF LABEL USE 45 0.0001
863 VISION BLURRED 7 0.0001
864 DRUG INEFFECTIVE 67 0.0001
865 WHEEZING 3 0.0001
866 DISABILITY 1 0.0001
867 SUICIDE ATTEMPT 3 0.0000
868 INJURY ASSOCIATED WITH DEVICE 1 0.0000
869 INJECTION SITE WARMTH 1 0.0000
870 TREMOR 8 0.0000
871 PRODUCT USE ISSUE 9 0.0000
872 DEATH 41 0.0000
873 KNEE ARTHROPLASTY 1 0.0000
874 IMPAIRED WORK ABILITY 1 0.0000
875 HYPERHIDROSIS 6 0.0000
876 HYPOACUSIS 2 0.0000
877 DEEP VEIN THROMBOSIS 3 0.0000
878 BLOOD CREATININE INCREASED 3 0.0000
879 CLOSTRIDIUM DIFFICILE INFECTION 1 0.0000
880 MELAENA 1 0.0000
881 APPLICATION SITE PAIN 1 0.0000
882 RENAL FAILURE 6 0.0000
883 GAMMA-GLUTAMYLTRANSFERASE INCREASED 1 0.0000
884 COLITIS ULCERATIVE 2 0.0000
885 DEVICE ISSUE 4 0.0000
886 CHROMATURIA 1 0.0000
887 MUSCLE TWITCHING 1 0.0000
888 COGNITIVE DISORDER 2 0.0000
889 DISEASE PROGRESSION 5 0.0000
890 ARRHYTHMIA 2 0.0000
891 MULTIPLE SCLEROSIS 2 0.0000
892 BLOOD GLUCOSE DECREASED 2 0.0000
893 HEPATIC CANCER 1 0.0000
894 INTERSTITIAL LUNG DISEASE 2 0.0000
895 CEREBRAL INFARCTION 1 0.0000
896 INJECTION SITE URTICARIA 1 0.0000
897 LIVER INJURY 1 0.0000
898 AGEUSIA 1 0.0000
899 GLYCOSYLATED HAEMOGLOBIN INCREASED 1 0.0000
900 ABDOMINAL PAIN LOWER 1 0.0000
901 GASTRIC CANCER 1 0.0000
902 DIABETES MELLITUS 3 0.0000
903 LOSS OF CONSCIOUSNESS 5 0.0000
904 DRUG RESISTANCE 1 0.0000
905 DIPLOPIA 1 0.0000
906 NERVOUSNESS 2 0.0000
907 MUCOSAL INFLAMMATION 1 0.0000
908 APPLICATION SITE ERYTHEMA 1 0.0000
909 INCORRECT DOSE ADMINISTERED BY DEVICE 1 0.0000
910 INJECTION SITE BRUISING 3 0.0000
911 INJECTION SITE HAEMORRHAGE 3 0.0000
912 DEHYDRATION 5 0.0000
913 BREAST CANCER FEMALE 1 0.0000
914 MENSTRUATION IRREGULAR 1 0.0000
915 FEAR 1 0.0000
916 PAIN OF SKIN 1 0.0000
917 FREQUENT BOWEL MOVEMENTS 1 0.0000
918 WHITE BLOOD CELL COUNT DECREASED 4 0.0000
919 LIMB INJURY 1 0.0000
920 PALLOR 1 0.0000
921 TREATMENT NONCOMPLIANCE 2 0.0000
922 MENTAL STATUS CHANGES 1 0.0000
923 INJECTION SITE PAIN 11 0.0000
924 EYE PAIN 2 0.0000
925 BALANCE DISORDER 3 0.0000
926 LIVER FUNCTION TEST ABNORMAL 1 0.0000
927 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
928 SURGERY 2 0.0000
929 IRRITABILITY 2 0.0000
930 CONTRAINDICATED PRODUCT ADMINISTERED 1 0.0000
931 ILL-DEFINED DISORDER 2 0.0000
932 EPILEPSY 1 0.0000
933 INJECTION SITE RASH 1 0.0000
934 ADVERSE EVENT 3 0.0000
935 INJECTION SITE ERYTHEMA 4 0.0000
936 DRUG INTERACTION 5 0.0000
937 MOOD SWINGS 1 0.0000
938 HYPOTHYROIDISM 1 0.0000
939 ATRIAL FIBRILLATION 3 0.0000
940 FALL 10 0.0000
941 HEPATIC ENZYME INCREASED 2 0.0000
942 HAEMOGLOBIN DECREASED 3 0.0000
943 NIGHTMARE 1 0.0000
944 DEVICE USE ERROR 1 0.0000
945 HAEMORRHAGE 3 0.0000
946 HEART RATE DECREASED 1 0.0000
947 CEREBRAL HAEMORRHAGE 1 0.0000
948 CONSTIPATION 6 0.0000
949 DYSGEUSIA 2 0.0000
950 UNEVALUABLE EVENT 2 0.0000
951 INCORRECT DOSE ADMINISTERED 6 0.0000
952 ANAEMIA 5 0.0000
953 INJECTION SITE SWELLING 2 0.0000
954 HOSPITALISATION 4 0.0000
955 DECREASED APPETITE 6 0.0000
956 THROMBOSIS 2 0.0000
957 DEVICE BREAKAGE 1 0.0000
958 COMPLETED SUICIDE 2 0.0000
959 CARDIO-RESPIRATORY ARREST 1 0.0000
960 PSORIASIS 3 0.0000
961 MYOCARDIAL INFARCTION 4 0.0000
962 INTENTIONAL PRODUCT MISUSE 2 0.0000
963 ANGIOEDEMA 1 0.0000
964 MATERNAL EXPOSURE DURING PREGNANCY 2 0.0000
965 ADVERSE DRUG REACTION 2 0.0000
966 BLOOD CHOLESTEROL INCREASED 1 0.0000
967 PULMONARY EMBOLISM 2 0.0000
968 DYSPEPSIA 2 0.0000
969 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 4 0.0000
970 ECZEMA 1 0.0000
971 DERMATITIS ATOPIC 1 0.0000
972 DISTURBANCE IN ATTENTION 1 0.0000
973 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
974 CATARACT 1 0.0000
975 ALANINE AMINOTRANSFERASE INCREASED 1 0.0000
976 BLOOD GLUCOSE INCREASED 3 0.0000
977 FEBRILE NEUTROPENIA 1 0.0000
978 INJECTION SITE REACTION 1 0.0000
979 AGITATION 1 0.0000
980 HALLUCINATION 1 0.0000
981 CHRONIC KIDNEY DISEASE 1 0.0000
982 GASTROOESOPHAGEAL REFLUX DISEASE 1 0.0000
983 FOETAL EXPOSURE DURING PREGNANCY 1 0.0000
984 INTENTIONAL PRODUCT USE ISSUE 1 0.0000
985 EMOTIONAL DISTRESS 1 0.0000
986 PRODUCT USE IN UNAPPROVED INDICATION 2 0.0000
987 ACUTE KIDNEY INJURY 1 0.0000
988 DRUG DEPENDENCE 1 0.0000